Shire's next deal could be "transformational" - the end?
I see that London-listed Shire has finally formally announced its £22 billion takeover of US rival Baxalta.
Perhaps it's time to start a new series about another FTSE 100 pharmaceutical company's plans to pursue a "transformational" deal?
So, keep an eye on little old Betaville later this week.....
Date: Monday, 11 January 2016, 2:22 pm